-

01:47:35 PM

ENDP Stock News

ENDP - Endo International plc

05/13/22 4:10 PM

Nasdaq : ENDP

Buxton Helmsley Issues Letter to Endo International Plc. Shareholders and Creditors, Relating to Corporate Malfeasance and False Statements of Financials

The Buxton Helmsley Group, Inc., the New York City- based investment advisor to clients with financial interests in Endo International Plc., today issued an open letter to shareholders and creditors of the Company, relating to corporate malfeasance and false statements of financial position. Board of Directors: Mark G. Barberio, Jennifer M. Chao, Blaise Coleman,...

RHEA-AI

neutral

05/05/22 4:30 PM

Nasdaq : ENDP

earnings

ENDO REPORTS FIRST-QUARTER 2022 FINANCIAL RESULTS

Endo International plc (NASDAQ: ENDP) today reported financial results for the first-quarter ended March 31, 2022 and provided second-quarter 2022 financial guidance."Despite challenging market dynamics for VASOSTRICT ®, our first-quarter financial performance

RHEA-AI

neutral

05/05/22 4:20 PM

Nasdaq : ENDP

clinical trial

Endo Aesthetics to Introduce New Clinical Study of Qwo® (collagenase clostridium histolyticum-aaes) at the Annual SCALE Meeting

Endo International plc (NASDAQ: ENDP) today announced the upcoming launch of a new clinical study relevant to the use of Qwo ® (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. The

RHEA-AI

neutral

05/02/22 7:55 AM

Nasdaq : ENDP

acquisition

Endo Acquires Six Development-Stage, Ready-to-Use Injectable Product Candidates From Nevakar

Endo International plc (NASDAQ: ENDP) announced today that its subsidiary Endo Ventures Limited (EVL) acquired six development-stage, ready-to-use injectable product candidates from Nevakar Injectables Inc., a subsidiary of Nevakar, Inc."These six product

RHEA-AI

neutral

04/20/22 5:23 PM

Nasdaq : ENDP

Tennessee Court of Appeals Orders Recusal of Trial Court Judge and Vacates Default Judgment on Liability Against Endo

Endo International plc (NASDAQ: ENDP) today announced that the Tennessee Court of Appeals has reversed a trial court judge's order denying a motion for recusal by Endo's wholly-owned subsidiaries Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.

RHEA-AI

very negative

04/12/22 5:00 PM

Nasdaq : ENDP

earnings

Endo to Announce First-Quarter 2022 Financial Results

Endo International plc (NASDAQ: ENDP) will announce its first–quarter 2022 financial results on May 5, 2022 and members of its senior management team will host a conference call and webcast on May 6, 2022 at 7:30am ET before the U.S. financial markets

RHEA-AI

neutral

03/28/22 7:30 AM

Nasdaq : ENDP

Endo Begins Shipment of Premixed Ephedrine Sulfate Injection in Ready-to-Use Vials

Endo International plc (NASDAQ: ENDP) announced today that its Par Sterile Products business has begun shipping premixed Ephedrine Sulfate Injection in a ready-to-use 50 mg/10 ml single-use vial."We are pleased to launch this new ready-to-use product as

RHEA-AI

very positive

03/03/22 4:30 PM

Nasdaq : ENDP

Endo Launches New Living Our Values Program to Recognize Outstanding Team Members

Endo International plc (NASDAQ: ENDP) today honored select team members from across the world who exemplify Endo's Values as part of its inaugural Living Our Values Award program."At Endo, we are motivated by a strong sense of purpose. We believe our Values –

RHEA-AI

very positive

03/02/22 9:15 AM

Nasdaq : ENDP

Butt First: Endo Launches First Direct-to-Consumer Campaign for Qwo® (collagenase clostridium histolyticum-aaes) With 200+ Patient Events

Endo International plc (NASDAQ: ENDP) has kicked off a series of more than 200 patient events that will be held across the United States as part of Butt First, a new direct-to-consumer awareness campaign designed to excite and educate women about Endo

RHEA-AI

neutral

02/28/22 4:15 PM

Nasdaq : ENDP

earnings

ENDO REPORTS FOURTH-QUARTER AND FULL-YEAR 2021 FINANCIAL RESULTS

Endo International plc (NASDAQ: ENDP) today reported financial results for the fourth-quarter and full-year ended December 31, 2021 and introduced first-quarter 2022 financial guidance."Endo's solid operational and financial performance in the fourth-quarter

RHEA-AI

neutral

1 2 3 4 5 6 7 8 9 10 Next